Lucera Erick (CIK 1697616) reported 6 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-26). Recent activity: Sell DYN (2,362 shares), Sell DYN (1,448 shares), Sell DYN (5,727 shares), Buy DYN (65,000 shares), Buy DYN (66,100 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-26 | Dyne Therapeutics, Inc. (DYN) | Chief Financial Officer | Sell | 2,362 | $48,114 |
| 2026-05-14 | Dyne Therapeutics, Inc. (DYN) | Chief Financial Officer | Sell | 1,448 | $26,585 |
| 2026-04-03 | Dyne Therapeutics, Inc. (DYN) | Chief Financial Officer | Sell | 5,727 | $106,751 |
| 2026-02-17 | Dyne Therapeutics, Inc. (DYN) | Chief Financial Officer | Buy | 65,000 | $0 |
| 2025-04-01 | Dyne Therapeutics, Inc. (DYN) | Chief Financial Officer | Buy | 66,100 | $0 |
| 2025-03-05 | Editas Medicine, Inc. (EDIT) | EVP, CHIEF FINANCIAL OFFICER | Sell | 4,109 | $7,026 |
Source: SEC Form 4 filings · as of 2026-06-26